Display options
Cite
Palaniappan SK, Than NN, Thein AW, et al. Interventions for preventing and managing advanced liver disease in cystic fibrosis. Cochrane Database Syst Rev. 2017;8:CD012056doi: 10.1002/14651858.CD012056.pub2.
Palaniappan, S. K., Than, N. N., Thein, A. W., Moe, S., & van Mourik, I. (2017). Interventions for preventing and managing advanced liver disease in cystic fibrosis. The Cochrane database of systematic reviews, 8CD012056. https://doi.org/10.1002/14651858.CD012056.pub2
Palaniappan, Senthil K, et al. "Interventions for preventing and managing advanced liver disease in cystic fibrosis." The Cochrane database of systematic reviews vol. 8 (2017): CD012056. doi: https://doi.org/10.1002/14651858.CD012056.pub2
Palaniappan SK, Than NN, Thein AW, Moe S, van Mourik I. Interventions for preventing and managing advanced liver disease in cystic fibrosis. Cochrane Database Syst Rev. 2017 Aug 29;8:CD012056. doi: 10.1002/14651858.CD012056.pub2. PMID: 28850173; PMCID: PMC6483789.
Copy Download .nbib Format: NLM
Share it on

Cochrane Database Syst Rev. 2017 Aug 29;8:CD012056. doi: 10.1002/14651858.CD012056.pub2.

Interventions for preventing and managing advanced liver disease in cystic fibrosis.

The Cochrane database of systematic reviews

Senthil K Palaniappan, Nan Nitra Than, Aung Win Thein, Soe Moe, Indra van Mourik

Affiliations

  1. Department of Medicine, University Hospitals of Leicester, NHS trust, Leicester Royal Infirmary, Leicester, UK, LE1 5WW.

PMID: 28850173 PMCID: PMC6483789 DOI: 10.1002/14651858.CD012056.pub2

Abstract

BACKGROUND: Cystic fibrosis is an autosomal recessive inherited defect in the cystic fibrosis transmembrane conductance regulator (CFTR) gene resulting in abnormal regulation of salt and water movement across the membranes. In the liver this leads to focal biliary fibrosis resulting in progressive portal hypertension and end-stage liver disease in some individuals. This can be asymptomatic, but may lead to splenomegaly and hypersplenism, development of varices and variceal bleeding, and ascites; it has negative impact on overall nutritional status and respiratory function in this population. Prognosis is poor once significant portal hypertension is established. The role and outcome of various interventions for managing advanced liver disease (non-malignant end stage disease) in people with cystic fibrosis is currently unidentified.

OBJECTIVES: To review and assess the efficacy of currently available treatment options for preventing and managing advanced liver disease in children and adults with cystic fibrosis.

SEARCH METHODS: We searched the Cochrane Cystic Fibrosis Trials Register, compiled from electronic database searches and handsearching of journals and conference abstract books.Date of last search: 06 April 2017.We also searched the reference lists of relevant articles and reviews and online trials registries. Date of last search: 04 January 2017.

SELECTION CRITERIA: Any published and unpublished randomised controlled trials and quasi-randomised controlled trials of advanced liver disease in cystic fibrosis with cirrhosis or liver failure, portal hypertension or variceal bleeding (or both).

DATA COLLECTION AND ANALYSIS: Authors independently examined titles and abstracts to identify potentially relevant trials, but none were eligible for inclusion in this review.

MAIN RESULTS: A comprehensive search of the literature did not identify any published eligible randomised controlled trials.

AUTHORS' CONCLUSIONS: In order to develop the best source of evidence, there is a need to undertake randomised controlled trials of interventions for preventing and managing advanced liver disease in adults and children with cystic fibrosis.

References

  1. J Pediatr Gastroenterol Nutr. 1999 Jul;29(1):12-7 - PubMed
  2. J Hepatol. 1999 Jul;31(1):77-83 - PubMed
  3. Hepatology. 1999 Nov;30(5):1151-8 - PubMed
  4. Clin Radiol. 2000 Mar;55(3):236-7 - PubMed
  5. Turk J Pediatr. 2000 Jan-Mar;42(1):31-3 - PubMed
  6. Endoscopy. 2000 Dec;32(12):931-4 - PubMed
  7. J Gastroenterol Hepatol. 2002 Feb;17(2):208-13 - PubMed
  8. Hepatology. 2002 Dec;36(6):1374-82 - PubMed
  9. Hepatogastroenterology. 2003 Jul-Aug;50(52):1111-4 - PubMed
  10. J Pediatr Surg. 2003 Aug;38(8):1152-6 - PubMed
  11. World J Gastroenterol. 2003 Aug;9(8):1836-9 - PubMed
  12. Langenbecks Arch Surg. 2003 Jul;388(3):141-9 - PubMed
  13. Hepatology. 1992 Oct;16(4):924-30 - PubMed
  14. Eur J Gastroenterol Hepatol. 2003 Oct;15(10):1073-8 - PubMed
  15. Hepatology. 2004 Jun;39(6):1673-82 - PubMed
  16. J Hepatol. 2004 Dec;41(6):920-5 - PubMed
  17. J Hepatol. 2005 Jul;43(1):167-76 - PubMed
  18. Am J Respir Crit Care Med. 2006 Mar 1;173(5):475-82 - PubMed
  19. Liver Transpl. 2005 Dec;11(12):1522-6 - PubMed
  20. Am J Dis Child. 1991 Dec;145(12):1401-4 - PubMed
  21. Can J Gastroenterol. 2006 Jul;20(7):475-8 - PubMed
  22. Transpl Int. 2006 Sep;19(9):726-31 - PubMed
  23. Curr Treat Options Gastroenterol. 2006;9(6):484-96 - PubMed
  24. Am J Gastroenterol. 2007 Sep;102(9):2086-102 - PubMed
  25. Pediatr Pulmonol. 2007 Dec;42(12):1173-80 - PubMed
  26. Am J Transplant. 2008 Jan;8(1):162-9 - PubMed
  27. Surg Today. 2008;38(1):26-9 - PubMed
  28. J Cyst Fibros. 2008 Sep;7(5):450-3 - PubMed
  29. Respir Med. 2009 Apr;103(4):629-35 - PubMed
  30. Curr Opin Gastroenterol. 2009 May;25(3):272-8 - PubMed
  31. Chest. 2009 Jun;135(6):1610-1618 - PubMed
  32. J Cyst Fibros. 2009 Dec;8(6):392-9 - PubMed
  33. JAMA. 2009 Sep 9;302(10):1076-83 - PubMed
  34. Pediatr Radiol. 2010 Jul;40(7):1231-5 - PubMed
  35. Pediatr Transplant. 2010 Sep 1;14(6):779-85 - PubMed
  36. Am J Gastroenterol. 2011 Jan;106(1):104-9 - PubMed
  37. Curr Gastroenterol Rep. 2011 Feb;13(1):10-6 - PubMed
  38. Pediatr Transplant. 2010 Dec;14(8):954-60 - PubMed
  39. Liver Transpl. 2011 Mar;17(3):243-50 - PubMed
  40. J Cyst Fibros. 2011 Sep;10(5):338-42 - PubMed
  41. Pediatr Pulmonol Suppl. 1991;11(S1):130-131 - PubMed
  42. J Cyst Fibros. 2011 Jun;10 Suppl 2:S29-36 - PubMed
  43. Am J Transplant. 2012 Apr;12(4):954-64 - PubMed
  44. Pediatr Transplant. 2012 Aug;16(5):426-37 - PubMed
  45. World J Gastroenterol. 2012 Mar 21;18(11):1166-75 - PubMed
  46. World J Gastroenterol. 2012 Mar 21;18(11):1176-84 - PubMed
  47. Ann Hepatol. 2012 May-Jun;11(3):369-83 - PubMed
  48. Cochrane Database Syst Rev. 2012 Aug 15;(8):CD004544 - PubMed
  49. J Cyst Fibros. 2013 Mar;12(2):116-24 - PubMed
  50. Liver Int. 2013 May;33(5):698-705 - PubMed
  51. Prz Gastroenterol. 2014;9(3):136-41 - PubMed
  52. J Gastroenterol Hepatol. 2014 Dec;29(12):1954-62 - PubMed
  53. Lancet. 1989 Dec 16;2(8677):1422-5 - PubMed
  54. Can J Gastroenterol Hepatol. 2015 Apr;29(3):139-44 - PubMed
  55. Surgery. 1989 Feb;105(2 Pt 1):160-5 - PubMed
  56. J Pediatr. 1987 Oct;111(4):501-6 - PubMed
  57. Pediatrics. 1987 Oct;80(4):571-4 - PubMed
  58. Pediatrics. 1987 Oct;80(4):517-23 - PubMed
  59. Am J Clin Nutr. 1987 Oct;46(4):606-13 - PubMed
  60. J Pediatr. 1985 Feb;106(2):317-21 - PubMed
  61. Pediatr Res. 1985 Jun;19(6):578-82 - PubMed
  62. Lancet. 1995 Nov 4;346(8984):1230-1 - PubMed
  63. Hepatology. 1995 Jul;22(1):332-54 - PubMed
  64. J Pediatr Gastroenterol Nutr. 1994 Aug;19(2):198-203 - PubMed
  65. Arch Dis Child. 1994 Oct;71(4):349-52 - PubMed
  66. Arch Dis Child. 1993 Sep;69(3):407 - PubMed
  67. J Pediatr Surg. 1977 Apr;12(2):201-6 - PubMed
  68. J Pediatr. 1995 Dec;127(6):881-7 - PubMed
  69. Hepatology. 1996 Jun;23(6):1484-90 - PubMed
  70. J R Soc Med. 1996;89 Suppl 27:31-7 - PubMed
  71. Eur J Gastroenterol Hepatol. 1996 May;8(5):477-83 - PubMed
  72. J Pediatr Surg. 1996 Aug;31(8):1056-9 - PubMed
  73. J Pediatr. 1997 Jan;130(1):52-8 - PubMed
  74. Scand J Gastroenterol. 1997 Apr;32(4):369-73 - PubMed

MeSH terms

Publication Types